Philip Morris International Collection

This collection contains Philip Morris International (PMI) documents acquired outside of US litigation.

Topics include a study acquired by the Organized Crime and Corruption Reporting Project (OCCRP) for a piece on PMI's marketing of IQOS; documents acquired by Reuters News for their series of stories "Inside Philip Morris" concerning Philip Morris International's (PMI) use of resources to combat the WHO FCTC; their marketing of the Marlboro brand in India; clinical trial complications of iQOS; lobbying various health officials in an effort to distance the iQOS device from traditional smoking and cigarettes; and funding of scientists at Japanese universities to influence research.

Related Resources

• Braznell, S., Laurence, L., Fitzpatrick, I., Gilmore, A.B. (2024). “Keep it a secret”: Leaked documents suggest Philip Morris International, and its Japanese affiliate, continue to exploit science for profit. Nicotine & Tobacco Research, ntae101, https://doi.org/10.1093/ntr/ntae101.
• Johnston, F. (2024, July 1). Science for sale: Philip Morris’s web of payments to fund tobacco research. The Bureau of Investigative Journalism. https://www.thebureauinvestigates.com/stories/2024-07-01/science-for-sale-philip-morris-web-of-payments-to-fund-tobacco-research/.
• Lay, K. (2024, June 28). Tobacco giant accused of ‘manipulating science’ to attract non-smokers. The Guardian. https://www.theguardian.com/global-development/article/2024/jun/28/tobacco-giant-philip-morris-pmi-accused-manipulating-science-attract-nonsmokers-iqos-targeting-politicians-doctors-tokyo-olympics.